Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Revenue: 2011-2024

Historic Revenue for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to $38,000.

  • Abeona Therapeutics' Revenue rose 786.21% to $771,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 94.80%. This contributed to the annual value of $38,000 for FY2024, which is 98.91% down from last year.
  • Latest data reveals that Abeona Therapeutics reported Revenue of $38,000 as of FY2024, which was down 98.91% from $3.5 million recorded in FY2023.
  • Abeona Therapeutics' 5-year Revenue high stood at $10.0 million for FY2020, and its period low was $38,000 during FY2024.
  • For the 3-year period, Abeona Therapeutics' Revenue averaged around $1.7 million, with its median value being $1.4 million (2022).
  • In the last 5 years, Abeona Therapeutics' Revenue skyrocketed by 147.52% in 2023 and then crashed by 98.91% in 2024.
  • Abeona Therapeutics' Revenue (Yearly) stood at $10.0 million in 2020, then crashed by 70.00% to $3.0 million in 2021, then crashed by 52.87% to $1.4 million in 2022, then skyrocketed by 147.52% to $3.5 million in 2023, then plummeted by 98.91% to $38,000 in 2024.